-transparent.png){kind=logo}
Abnormalities in uric acid metabolism are associated with uric acid and calcium oxalate urolithiasis. Clinical stone formation depends on multiple identifiable risk factors that affect uric acid and calcium oxalate solubility. The understanding of urinary pH is critical to direct appropriate treatment of uric acid-related nephrolithiasis. Understanding uric acid metabolism and the pathophysiology of uric acid and calcium oxalate stone formation leads to a rational treatment approach to uric acid and hyperuricosuric calcium oxalate stone disease.
Related Publications
R K Low, and
M L Stoller
August 2007,
The Urologic clinics of North America,
R K Low, and
M L Stoller
January 2015,
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
R K Low, and
M L Stoller
November 1968,
The American journal of medicine,
R K Low, and
M L Stoller
January 1994,
Mineral and electrolyte metabolism,
R K Low, and
M L Stoller
July 1978,
Archives of internal medicine,
R K Low, and
M L Stoller
December 2002,
Endocrinology and metabolism clinics of North America,
R K Low, and
M L Stoller
September 1992,
The Journal of urology,
